Vyvanse 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB26FWGCH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,629
Award facts
- Contract value 100% obligated
- $3,628.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,628.69 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, executes this order under its prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that supports comprehensive pharmaceutical and medical supply needs for military healthcare programs worldwide.
As a child delivery order under the SPE2DX prime contract, this award reflects AmerisourceBergen Drug Corp's established capability to supply specialized pharmaceutical products to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government medical programs. The vendor's portfolio demonstrates consistent competitively awarded contracts across diverse therapeutic domains, with the firm serving as a primary pharmaceutical supplier through DLA's Medical Supply Chain. This delivery order for Vyvanse, a controlled-substance medication used in attention deficit treatment, represents routine pharmaceutical procurement supporting military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FWGCH?
SPE2DB26FWGCH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FWGCH worth?
The government has obligated $3,629 on SPE2DB26FWGCH.
Is contract SPE2DB26FWGCH an order under another contract?
Yes. SPE2DB26FWGCH is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWGCH competed?
The extent of competition for SPE2DB26FWGCH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award